Informations générales (source: ClinicalTrials.gov)
National Cohort on Imprinting Disorders and Their Metabolic Consequences (IDMet)
Observational
Institut National de la Santé Et de la Recherche Médicale, France (Voir sur ClinicalTrials)
mars 2017
mars 2028
05 avril 2025
The goal of this observational study is to describe the natural history of imprinting
disorders (IDs) according to their metabolic profile in all patients (adults and
children) affected with an ID regardless of the severity of the disease, with a molecular
characterization, with a signed informed consent for all subjects, followed in one
partner's center.
The main questions it aims to answer are:
- Can we identify common metabolic profiles for all imprinted diseases?
- Which imprinting disorders have an impact on the metabolic profiles of IDs?
- Which are the metabolic risks associated to IDs?
- Can we use the metabolic profiles for the clinical classification and prognosis of
IDs?
- Are there common therapeutic approaches for all IDs?
Etablissements
Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
AP-HP - Hôpital Armand Trousseau-La Roche Guyon | Irène NETCHINE | Contact (sur clinicalTrials) | |||
AP-HP - Hôpital Necker-Enfants Malades | Graziella PINTO | Contact (sur clinicalTrials) | |||
Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
CHU d'Angers - Angers - France | Patrice RODIEN | Contact (sur clinicalTrials) | |||
Hôpital Bicêtre - Le Kremlin-Bicêtre - France | Agnès LINGLART | Contact (sur clinicalTrials) | |||
Hôpital Brabois - Nancy - France | Bruno LEHEUP | Contact (sur clinicalTrials) | |||
Hôpital Bretonneau - Tours - France | Peggy PIERRE | Contact (sur clinicalTrials) | |||
Hôpital Civil - Strasbourg - France | Nathalie GAUTHIER-JEANDIDIER | Contact (sur clinicalTrials) | |||
Hôpital de la mère et de l'enfant - Limoges - France | Anne LIENHARDT ROUSSIE | Contact (sur clinicalTrials) | |||
Hôpital de la Pitié-Salpêtrière - Paris - France | Christine POITOU-BERNERT | Contact (sur clinicalTrials) | |||
Hôpital de la Timone - Marseille - France | Tiffany BUSA | Contact (sur clinicalTrials) | |||
Hôpital des Enfants - Toulouse - France | Jean-Pierre SALLES | Contact (sur clinicalTrials) | |||
Hôpital enfant-adolescent - Nantes - France | Sabine BARON | Contact (sur clinicalTrials) | |||
Hôpital Femme Mère Enfant - Lyon - France | Marc NICOLINO | Contact (sur clinicalTrials) | |||
Hôpital Gabriel Montpied - Clermont-Ferrand - France | Igor TAUVERON | Contact (sur clinicalTrials) | |||
Hôpital Jean Minjoz - Besançon - France | Brigitte MIGNOT | Contact (sur clinicalTrials) | |||
Hôpital Jeanne de Flandre - Lille - France | Maryse CARTIGNY | Contact (sur clinicalTrials) | |||
Hôpital Robert Debré - Paris - France | Nicolas DE ROUX | Contact (sur clinicalTrials) | |||
Hôpital Sud - Rennes - France | Sylvie ODENT | Contact (sur clinicalTrials) |
Critères
Tous
Inclusion Criteria:
- Patients (adults and children) affected with an ID regardless of the severity of the
disease
- A confirmed diagnosis of ID (based on molecular diagnosis)
- A signed informed consent for adults or signed informed consent of parents/guardians
of minors/ protected adult.
Non-Inclusion Criteria:
There are no non-inclusion criteria.
- Patients (adults and children) affected with an ID regardless of the severity of the
disease
- A confirmed diagnosis of ID (based on molecular diagnosis)
- A signed informed consent for adults or signed informed consent of parents/guardians
of minors/ protected adult.
Non-Inclusion Criteria:
There are no non-inclusion criteria.